CDC Releases Maternal Immunization Vital Signs Report

Oct 08, 2019 | Kimberly Sharpe-Scott

Today, CDC released its October 2019 Vital Signs Report, “Burden and Prevention of Influenza and Pertussis Among U.S. Pregnant Women and Infants.” This report includes the latest findings on influenza and Tdap (whooping cough) vaccination rates among pregnant women. Key points from the report include:

Currently, the rates for these vaccines are too low – only 1 in 3 pregnant women in the United States receives both flu and Tdap vaccines. We don’t want to miss any opportunity for pregnant women to protect themselves and their newborns from these devastating illnesses. Flu vaccination lowers risk of influenza hospitalization in pregnant women by an average of 40%. It also reduces the risk of her baby needing hospital care for influenza. When an expecting mother gets Tdap in the third trimester, it is 78% effective in preventing cases of whooping cough in babies less than 2 months old. Tdap vaccination during pregnancy is even more effective at preventing hospitalization due to whooping cough in newborns.

Data indicate that education, referring patients to a vaccine provider, and the offer of vaccination by a provider play a significant role with getting vaccinated. Among women whose healthcare providers offered vaccination or provided referrals, 65.7% received a flu vaccine and 70.5% received Tdap. By encouraging vaccinations during pregnancy, mothers can make an informed choice to protect themselves and give their babies early protection.

Below are other key points from the report:

  • Women with influenza are more than twice as likely to be hospitalized if they are pregnant, and babies less than 6 months old are at the highest risk of all children for influenza-associated hospitalization.
  • The majority (69%) of reported whooping cough deaths are in babies less than 2 months old.
  • Reported maternal flu and Tdap vaccination coverage rates were 54% and 55%, respectively.
  • Provider recommendations are vital—among women whose healthcare providers offered vaccination or provided referrals, 65.7% received a flu vaccine and 70.5% received Tdap—but many pregnant women do not receive the vaccines recommended to protect themselves and their newborns, even when offered vaccination. The most commonly reported reasons for non-vaccination were belief that the flu vaccine is not effective (17.6%) and not knowing that Tdap vaccination is needed during each pregnancy (37.9%).
  • Providers should start discussing the benefits of vaccination with women early in pregnancy, strongly recommend flu and Tdap vaccines to all pregnant women, and address women’s questions and concerns about getting vaccinated during pregnancy.

Visit the Vital Signs website to access the MMWR article, a two-page consumer fact sheet, social media content, graphics and other informative tools and resources.


About Kimberly Sharpe-Scott

More posts by Kimberly Sharpe-Scott

Related Posts

Monkeypox
  • Tools & Resources
  • Infectious Disease

National Monkeypox Vaccine Strategy: Phase One

This week the Biden Administration released the first phase of its national...

Jun 30, 2022 | Beth Hess

National Monkeypox Vaccine Strategy: Phase One

Prevent meningococcal disease
  • Infectious Disease

New Resources: 2022 Meningococcal Disease Outbreak...

The CDC and Florida Department of Health have released new resources and...

Jun 29, 2022 | Kimberly Nalley

New Resources: 2022 Meningococcal Disease Outbreak...

Harm reduction shutterstock 1063076657
  • HIV, STI, & Viral Hepatitis
  • Policy Statement
  • Substance Use Disorder

NACCHO Announces the Release of Updated Harm Reduction...

In its updated Harm Reduction policy statement, the National Association of...

Jun 28, 2022 | Anjana Rao

NACCHO Announces the Release of Updated Harm Reduction...

NACCHO color pms321
  • Press Release
  • Access to Care
  • Health Equity & Social Justice
  • Maternal, Child, & Adolescent Health

NACCHO Statement on U.S. Supreme Court Decision on Dobbs...

Today, the U.S. Supreme Court announced its decision on Dobbs v. Jackson...

Jun 24, 2022 | Adriane Casalotti

NACCHO Statement on U.S. Supreme Court Decision on Dobbs...

Cdc hiv nhtd 2022 promo english square
  • HIV, STI, & Viral Hepatitis

Dear Colleague: National HIV Testing Day

A new Dear Colleague letter from the CDC’s Division of HIV Prevention discusses...

Jun 24, 2022 | Guest Author, Julia Zigman

Dear Colleague: National HIV Testing Day

  • Tools & Resources
  • Climate Change
  • Health & Disability

Preparing People with Disabilities for Climate Change:...

Learn why having the voices of people with disabilities directly at the table...

Jun 23, 2022 | Guest Author

Preparing People with Disabilities for Climate Change:...

Under5 Guidance

COVID-19 Vaccine Authorized and Recommended for Children...

After successfully submitting data from their respective clinical trials, the...

Jun 21, 2022 | Amiris Roberson, Program Analyst, Immunization

COVID-19 Vaccine Authorized and Recommended for Children...

Cdc hiv nhtd 2022 promo english square
  • HIV, STI, & Viral Hepatitis

HIV Testing is Self-Care: National HIV Testing Day is...

Join health department, federal, and community partners across the U.S. in...

Jun 17, 2022 | Julia Zigman

HIV Testing is Self-Care: National HIV Testing Day is...

MRC Logo
  • Press Release

NACCHO Announces $9.5 Million in Awards to Local Medical...

Largest awards to date will strengthen MRC Network’s ability to deploy a ready,...

Jun 14, 2022 | Beth Hess

NACCHO Announces $9.5 Million in Awards to Local Medical...

Back to Top